Can a daily pill help shed pounds? a new trial puts HRS-7535 to the test.
NCT ID NCT06904105
First seen Jul 27, 2026 · Last updated Jul 28, 2026 · Updated 1 time
Summary
This phase 3 trial is testing whether an experimental oral drug called HRS-7535 can help people with overweight or obesity lose weight. About 556 adults aged 18 to 75 with a body mass index (BMI) of 24 or higher (or 28 or higher) are taking either HRS-7535 or a placebo daily. Researchers are measuring weight loss and checking for side effects to see if the drug is both effective and safe.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- an experimental oral drug called HRS-7535
- What this could lead to
- If successful, this could offer a new oral medication for weight loss in people who are overweight or obese.
- What could go wrong
- This is an early phase 3 trial, so the drug may not prove effective or could have side effects. Results may not apply to everyone.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for OBESITY are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Chinese PLA General Hospital
Beijing, Beijing Municipality, 100039, China
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a new stomach and gut bypass surgery tackle obesity and diabetes?
- Can a Two-Drug combo tip the scales against obesity?
- Can Weight-Loss surgery change how medications work?
- Coffee grounds probiotic could reshape gut health and fight inflammation
- Can shedding pounds reboot the Heart's exercise engine?
- Can stomach surgery alter how painkillers work?